SVB Wealth’s RenovoRx RNXT Stock Holding History

SVB Wealth’s Portfolio RNXT Stock Details RNXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,094	Closed	-$1.08K	–	1386
2025 Q1	$1.08K	Buy	+1,094	New	+$1.27K	﹤0.01%	1339

Other funds holding RNXT

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NPT

Nixon Peabody Trust Boston, Massachusetts $1.26B AUM 24.14% 1-Year Est. Return

CCM

Corsair Capital Management New York $673M AUM 109.99% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

SVB Wealth's RNXT Position: Q2 2025 in Review

SVB Wealth sold out of RenovoRx (RNXT) in Q2 2025, closing a stake of 1,094 shares — an estimated $1.08K sold.

SVB Wealth first reported a position in RNXT in Q1 2025 and held it in 1 quarter. The position peaked at $1.08K in Q1 2025. 25 funds tracked by Wall St. Rank hold RNXT as of Q2 2025.

SVB Wealth reported no remaining RenovoRx position as of Q2 2025 after selling out during the quarter.
SVB Wealth sold 1,094 RenovoRx shares in Q2 2025, an estimated $1.08K.
SVB Wealth first reported a position in RenovoRx in Q1 2025 and held it in 1 quarter.
SVB Wealth's RenovoRx position peaked at $1.08K in Q1 2025.
25 funds tracked by Wall St. Rank held RenovoRx as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.